National Cancer Institute; Notice of Meeting, 32989-32990 [06-5149]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 109 / Wednesday, June 7, 2006 / Notices
alternative approach may be used if
such approach satisfies the
requirements of the applicable statute
and regulations.
III. Electronic Access
Persons interested in obtaining a copy
of the guidance may do so by using the
Internet. To receive ‘‘Class II Special
Controls Guidance Document: Olfactory
Test Device,’’ you may either send an email request to dsmica@fda.hhs.gov to
receive an electronic copy of the
document or send a fax request to 240–
276–3151 to receive a hard copy. Please
use the document number 1595 to
identify the guidance you are
requesting.
CDRH maintains an entry on the
Internet for easy access to information
including text, graphics, and files that
may be downloaded to a personal
computer with Internet access. Updated
on a regular basis, the CDRH home page
includes device safety alerts, Federal
Register reprints, information on
premarket submissions [including lists
of approved applications and
manufacturers’ addresses], small
manufacturer’s assistance, information
on video conferencing and electronic
submissions, Mammography Matters,
and other device-oriented information.
The CDRH Web site may be accessed at
https://www.fda.gov/cdrh. A search
capability for all CDRH guidance
documents is available at https://
www.fda.gov/cdrh/guidance.html.
Guidance documents are also available
on the Division of Dockets Management
Internet site at https://www.fda.gov/
ohrms/dockets.
rwilkins on PROD1PC63 with NOTICES
IV. Paperwork Reduction Act of 1995
This guidance contains information
collection provisions that are subject to
review by the Office of Management and
Budget (OMB) under the Paperwork
Reduction Act of 1995 (the PRA) (44
U.S.C. 3501–3520). The collections of
information addressed in the guidance
document have been approved by OMB
in accordance with the PRA under the
regulations governing premarket
notification submissions (21 CFR part
807, subpart E, OMB control number
0910–0120). The labeling provisions
addressed in the guidance have been
approved by OMB under OMB control
number 0910–0485.
V. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES), written or electronic
comments regarding this document.
Submit a single copy of electronic
comments or two paper copies of any
mailed comments, except that
VerDate Aug<31>2005
17:54 Jun 06, 2006
Jkt 208001
32989
individuals may submit one paper copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. Comments
received may be seen in the Division of
Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Dated: May 24, 2006.
Linda S. Kahan,
Deputy Director, Center for Devices and
Radiological Health.
[FR Doc. E6–8792 Filed 6–6–06; 8:45 am]
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: May 31, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5146 Filed 6–6–06; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Board of Scientific Counselors for Basic
Sciences National Cancer Institute. The
meeting will be closed to the public as
indicated below in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Cancer Institutes, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors for Basic Sciences National
Cancer Institute.
Date: July 10, 2006.
Time: 11 a.m. to 4 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
National Cancer Institute, 9000 Rockville
Pike, Building 31/Conference Room 6,
Bethesda, MD 20892.
Time: 7 p.m. to 11 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
National Cancer Institute, 9000 Rockville
Pike, Building 31/Conference Room 6,
Bethesda, MD 20892.
Contact Person: Florence E. Farber, PhD.,
Executive Secretary, Office of the Director,
National Cancer Institute, National Institutes
of Health, 6116 Executive Boulevard, Room
2115, Bethesda, MD 20892. 301–496–7628.
ff6p@nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Cancer Institute Board of
Scientific Advisors.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Board of Scientific Advisors.
Date: June 29–30, 2006.
Time: June 29, 2006, 8 a.m. to 6 p.m.
Agenda: Director’s Report; Ongoing and
New Business; Reports Program Review
Group(s); and Budget Presentation; Reports of
Special Initiatives; RFA and RFP Concept
Review; and Scientific Presentations.
Place: National Institutes of Health,
Building 31, C Wing, 6 Floor, Conference Rm.
10, 9000 Rockville Pike, Bethesda, MD
20892.
Time: June 30, 2006, 8:30 a.m. to 1 p.m.
Agenda: Ongoing and New Business;
Reports of Program Review Group(s); and
Budget Presentation; Reports of Special
Initiatives; RFA and RFP Concept Review;
and Scientific Presentations.
Place: National Institutes of Health,
Building 31, C Wing, 6 Floor, Conference Rm.
10, 9000 Rockville Pike, Bethesda, MD
20892.
Contact Person: Paulette S. Gray, Ph.D.,
Executive Secretary, Director, Division of
E:\FR\FM\07JNN1.SGM
07JNN1
32990
Federal Register / Vol. 71, No. 109 / Wednesday, June 7, 2006 / Notices
Extramural Activities, National Cancer
Institute, National Institutes of Health, 6116
Executive Boulevard, 8th Floor, Rm. 8001,
Bethesda, MD 20892. 301–496–5147,
grayp@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/bsa.htm, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: May 31, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5149 Filed 6–6–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
rwilkins on PROD1PC63 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby giveen of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commerical
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Prevention,
Control and Population Sciences.
Date: June 19–21, 2006.
Time: 6 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Hasnaa Shafik, MD PhD,
Scientific Review Administrator, Division of
VerDate Aug<31>2005
17:54 Jun 06, 2006
Jkt 208001
Extramural Activities, RPRB, National Cancer
Institute, National Institutes of Health, 6116
Executive Blvd. Room 8037, Bethesda, MD
20892, (301) 451—4757,
shafikh@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Cancer
Prevention, Control, and Popoulation
Sciences.
Date: June 20–21, 2006.
Time: 12 p.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Shamala K. Srinivas, PhD,
Scientific Review Administrator, Grants
Review Branch, Division of Extramural
Activities, National Cancer Institute, National
Institutes of Health, 6116 Executive
Boulevard, Room 8133, Bethesda, MD 20892,
(301) 594–1224.
Name of Committee: National Cancer
Institute Special Emphasis Panel, RFA:
CA07–005, Advanced Proteomic Platforms
and Computation Sciences for the NCI
Clinical Proteomic Technologies Initiative.
Date: June 26–27, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Gaithersburg, 620 Perry
Parkway, Gaithersburg, MD 20877.
Contact Person: Kenneth L. Bielat, PhD,
Scientific Review Administrator, Division of
Extramural Activities, National Cancer
Institute, National Institutes of Health, 6116
Executive Boulevard, Room 7147, Bethesda,
MD 20892, (301) 496–7576,
bielatk@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, NIH Small
Grants Program for Cancer Epidemiology
PAR04–159 and Cancer Prevention PAR04–
147.
Date: July 11–13, 2006.
Time: 8 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Irina Gordienko, PhD,
Scientific Review Administrator, Scientific
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Blvd, Rm
7073, Bethesda, MD 20892, 301–594—1566,
gordienkoiv@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
Dated: May 31, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5151 Filed 6–6–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant application and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Initial Review
Group; Biomedical Research and Research
Training Review Subcommittee A.
Date: June 20, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Chevy Chase, 5520
Wisconsin Ave., Chevy Chase, MD 20815.
Contact Person: Carole H. Latker, Ph.D.,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, Natcher Building, Room 3AN18,
Bethesda, MD 20892. (301) 594–2848.
latkerc@nigms.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Initial Review
Group; Biomedical Research and Research
Training Review Subcommittee B.
Date: June 21, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Chevy Chase, 5520
Wisconsin Ave., Chevy Chase, MD 20815.
Contact Person: Arthur L. Zachary, Ph.D.,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, Natcher Building, Room 3AN–18,
Bethesda, MD 20892. (301) 594–2886.
zacharya@nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
E:\FR\FM\07JNN1.SGM
07JNN1
]]>Agencies
[Federal Register Volume 71, Number 109 (Wednesday, June 7, 2006)]
[Notices]
[Pages 32989-32990]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-5149]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the National Cancer Institute Board of Scientific Advisors.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: National Cancer Institute Board of Scientific
Advisors.
Date: June 29-30, 2006.
Time: June 29, 2006, 8 a.m. to 6 p.m.
Agenda: Director's Report; Ongoing and New Business; Reports
Program Review Group(s); and Budget Presentation; Reports of Special
Initiatives; RFA and RFP Concept Review; and Scientific
Presentations.
Place: National Institutes of Health, Building 31, C Wing, 6
Floor, Conference Rm. 10, 9000 Rockville Pike, Bethesda, MD 20892.
Time: June 30, 2006, 8:30 a.m. to 1 p.m.
Agenda: Ongoing and New Business; Reports of Program Review
Group(s); and Budget Presentation; Reports of Special Initiatives;
RFA and RFP Concept Review; and Scientific Presentations.
Place: National Institutes of Health, Building 31, C Wing, 6
Floor, Conference Rm. 10, 9000 Rockville Pike, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, Ph.D., Executive Secretary,
Director, Division of
[[Page 32990]]
Extramural Activities, National Cancer Institute, National
Institutes of Health, 6116 Executive Boulevard, 8th Floor, Rm. 8001,
Bethesda, MD 20892. 301-496-5147, grayp@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: deainfo.nci.nih.gov/advisory/bsa.htm, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: May 31, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-5149 Filed 6-6-06; 8:45 am]
BILLING CODE 4140-01-M
